Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|August 8, 2009
Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individualsG Rosignoli, C H Lim, M Bower, et al.
HIV Medicine|December 12, 2001
Detection and quantification of HIV-1 specific CD4 helper and CD8 cytotoxic cells: their role in HIV-1-infected individuals and vaccine recipientsN Imami, G Hardy, A Pires, et al.
AIDS Research and Human Retroviruses|December 2, 1999
Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapyN Imami, C Antonopoulos, G A Hardy, et al.
Transplantation|August 10, 1999
Lack of T cell proliferation without induction of nonresponsiveness after antigen presentation by endothelial cellsF M Marelli-Berg, L Frasca, N Imami, et al.
Scandinavian Journal of Immunology|August 1, 1996
Enhanced in vivo immunogenicity induced by an antibody to the IL-4 receptor-associated gp200-MR6 moleculeG B Sivolapenko, N Imami, M Larché, et al.
Tropical Medicine & International Health : TM & IH|August 30, 2000
Vaccines for the control of HIV/AIDSF Gotch, A Rutebemberwa, G Jones, et al.
Journal of Immune Based Therapies and Vaccines|September 27, 2005
Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapyA Pires, M Nelson, A L Pozniak, et al.
Clinical and Experimental Immunology|May 25, 2013
Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapyA A Herasimtschuk, B R Hansen, A Langkilde, et al.
Kidney International|March 21, 1998
Interferon-gamma-treated renal tubular epithelial cells induce allospecific toleranceL Frasca, F Marelli-Berg, N Imami, et al.
Clinical and Experimental Immunology|October 20, 2005
Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infectionC T Burton, M R Nelson, P Hay, et al.
Pageof 5